Peter Giunta focuses his practice on patent litigation in federal courts, the U.S. International Trade Commission (“ITC”), and the U.S. Court of Appeals for the Federal Circuit. He also has specific experience representing pharmaceutical clients in Hatch-Waxman patent litigations. Mr. Giunta represents clients in a wide array of technologies including pharmaceuticals, biomedical devices, and electronics, among others. He has represented clients Teva Pharmaceuticals, Sony, Impax Laboratories, and Dane Industrial Technologies, among others.
Mr. Giunta has handled phases of litigation through trial and appeal, including pleadings, motions, fact and expert discovery, and depositions. He has also composed trial and appellate briefs and motions, including Federal Circuit briefs, motions, and amicus briefs. Mr. Giunta also gained significant insight into litigation when he served as a law clerk to the Honorable Lawrence M. McKenna, U.S. District Court Judge in the Southern District of New York.
Before studying law, Mr. Giunta gained technical experience as an undergraduate intern in the analytical labs of several chemical and pharmaceutical companies.
- Otsuka Pharm. Co. Ltd. v. Teva Pharm. USA, Inc., (D.N.J. 2010) bench and trial appeal concerning Abilify® patent.
- Eli Lilly & Co. v. Teva Pharm. USA, Inc., (S.D. Ind. 2010; Fed. Cir. 2010) bench trial and appeal concerning Gemzar® patents.
- Procter & Gamble Co. v. Teva Pharm. USA, Inc., (D. Del. 2008; Fed Cir. 2009) bench trial and appeal concerning Actonel® patents.